Document is current
Any future updates will be listed below
-
Authors
Urrutia, Samuel
Takahashi, Koichi https://orcid.org/0000-0002-8027-9659
-
Funding
Funding for this research was provided by:
Leukemia and Lymphoma Society
Break Through Cancer
Conquer Cancer Foundation
- License Information
-
More Information
Article History
Received: 19 April 2024
Revised: 4 July 2024
Accepted: 24 July 2024
First Online: 1 August 2024
Declarations
:
: SU reports no conflict of interest. KT receives a consultancy fee from Symbio Pharmaceuticals, research grant from ASTEX and Jazz Pharmaceuticals, honoraria from Mission Bio, Illumina, Otsuka Pharmaceuticals, and Pfizer.
